{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38057373", "DateCompleted": {"Year": "2023", "Month": "12", "Day": "11"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "12", "Day": "06"}], "Language": ["eng"], "ELocationID": ["21489", "10.1038/s41598-023-48854-3"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "13", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Dec", "Day": "06"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "A natural product YSK-A blocks SARS-CoV-2 propagation by targeting multiple host genes.", "Pagination": {"StartPage": "21489", "MedlinePgn": "21489"}, "Abstract": {"AbstractText": ["Natural products and herbal medicine have been widely used in drug discovery for treating infectious diseases. Recent outbreak of COVID-19 requires various therapeutic strategies. Here, we used YSK-A, a mixture of three herbal components Boswellia serrata, Commiphora myrrha, and propolis, to evaluate potential antiviral activity against SARS-CoV-2. We showed that YSK-A inhibited SARS-CoV-2\u00a0propagation with an IC<sub>50</sub> values of 12.5\u00a0\u00b5g/ml and 15.42\u00a0\u00b5g/ml in\u00a0Vero E6\u00a0and\u00a0Calu-3\u00a0cells, respectively. Using transcriptome analysis, we further demonstrated that YSK-A modulated various host gene expressions in Calu-3 cells. Among these, we selected 9 antiviral- or immune-related host genes for further study. By siRNA-mediated knockdown experiment, we verified that MUC5AC, LIF, CEACAM1, and GDF15 host genes were involved in antiviral activity of YSK-A. Therefore, silencing of these genes nullified YSK-A-mediated inhibition of SARS-CoV-2 propagation. These data indicate that YSK-A displays an anti-SARS-CoV-2 activity by targeting multiple antiviral genes. Although the exact antiviral mechanism of each constituent has not been verified yet, our data indicate that YSK-A has an immunomodulatory effect on SARS-CoV-2 and thus it may represent a novel natural product-derived therapeutic agent for treating COVID-19."], "CopyrightInformation": "\u00a9 2023. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University, 820-120, Hana-Ro, Iksan, 54531, South Korea."}], "LastName": "Pham", "ForeName": "Thuy X", "Initials": "TX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University, 820-120, Hana-Ro, Iksan, 54531, South Korea."}], "LastName": "Huynh", "ForeName": "Trang T X", "Initials": "TTX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Veterinary Pathology, College of Veterinary Medicine, Jeonbuk National University, Iksan, South Korea."}], "LastName": "Kim", "ForeName": "Bumseok", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University, 820-120, Hana-Ro, Iksan, 54531, South Korea. yunsolim@hanmail.net."}], "LastName": "Lim", "ForeName": "Yun-Sook", "Initials": "YS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University, 820-120, Hana-Ro, Iksan, 54531, South Korea. sbhwang@jbnu.ac.kr."}, {"Identifier": [], "Affiliation": "Ilsong Institute of Life Science, Hallym University, Seoul, South Korea. sbhwang@jbnu.ac.kr."}], "LastName": "Hwang", "ForeName": "Soon B", "Initials": "SB"}], "GrantList": [{"GrantID": "2022R1A2B5B01001390", "Agency": "Ministry of Science and ICT, South Korea", "Country": ""}, {"GrantID": "2021R1A2C2003275", "Agency": "Ministry of Science and ICT, South Korea", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Hoareau L, DaSilva EJ. Medicinal plants: A re-emerging health aid. Electron. J. Biotechnol. 1999;2:3\u20134."}, {"Citation": "Jahan I, Ahmet O. Potentials of plant-based substance to inhabit and probable cure for the COVID-19. Turk. J. Biol. 2020;44:228. doi: 10.3906/biy-2005-114.", "ArticleIdList": ["10.3906/biy-2005-114", "PMC7314514", "32595359"]}, {"Citation": "Ang L, Lee HW, Choi JY, Zhang J, Lee MS. Herbal medicine and pattern identification for treating COVID-19: A rapid review of guidelines. Integr. Med. Res. 2020;9:100407. doi: 10.1016/j.imr.2020.100407.", "ArticleIdList": ["10.1016/j.imr.2020.100407", "PMC7104236", "32289016"]}, {"Citation": "Ngwe Tun MM, et al. The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro. J. Nat. Med. 2022;76:402\u2013409. doi: 10.1007/s11418-021-01596-w.", "ArticleIdList": ["10.1007/s11418-021-01596-w", "PMC8743439", "35006524"]}, {"Citation": "Matsabisa M, et al. In vitro study on efficacy of PHELA, an African traditional drug against SARS-CoV-2. Sci. Rep. 2022;12:10305. doi: 10.1038/s41598-022-13599-y.", "ArticleIdList": ["10.1038/s41598-022-13599-y", "PMC9207029", "35718800"]}, {"Citation": "WHO. WHO Coronavirus Disease (COVID-19) Dashboard. Accessed September 2023 (2023)."}, {"Citation": "Zou L, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020;382:1177\u20131179. doi: 10.1056/NEJMc2001737.", "ArticleIdList": ["10.1056/NEJMc2001737", "PMC7121626", "32074444"]}, {"Citation": "Ding Q, Lu P, Fan Y, Xia Y, Liu M. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan. China. J. Med. Virol. 2020;92:1549\u20131555. doi: 10.1002/jmv.25781.", "ArticleIdList": ["10.1002/jmv.25781", "PMC7228290", "32196707"]}, {"Citation": "Karki R, et al. Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184:149\u2013168. doi: 10.1016/j.cell.2020.11.025.", "ArticleIdList": ["10.1016/j.cell.2020.11.025", "PMC7674074", "33278357"]}, {"Citation": "Li G, Hilgenfeld R, Whitley R, De Clercq E. Therapeutic strategies for COVID-19: progress and lessons learned. Nat. Rev. Drug Discov. 2023;22(6):449\u2013475. doi: 10.1038/s41573-023-00672-y.", "ArticleIdList": ["10.1038/s41573-023-00672-y", "PMC10113999", "37076602"]}, {"Citation": "Yang M-S, et al. Antiviral and therapeutic effects of a mixture of Boswellia serrata, Commiphora myrrha, and Propolis for SARS-CoV-2. Nat. Prod. Commun. 2023;18:1934578X231180709."}, {"Citation": "Ramirez S, et al. Overcoming culture restriction for SARS-CoV-2 in human cells facilitates the screening of compounds inhibiting viral replication. Antimicrob. Agents Chemother. 2021;65(7):e0009721. doi: 10.1128/AAC.00097-21.", "ArticleIdList": ["10.1128/AAC.00097-21", "PMC8406809", "33903110"]}, {"Citation": "Diemer C, et al. Cell type-specific cleavage of nucleocapsid protein by effector caspases during SARS Coronavirus infection. J. Mol. Biol. 2008;376:23\u201334. doi: 10.1016/j.jmb.2007.11.081.", "ArticleIdList": ["10.1016/j.jmb.2007.11.081", "PMC7094231", "18155731"]}, {"Citation": "Lim YS, et al. Asunaprevir, a potent hepatitis C virus protease inhibitor, blocks SARS-CoV-2 propagation. Mol. Cells. 2021;44(9):688\u2013695. doi: 10.14348/molcells.2021.0076.", "ArticleIdList": ["10.14348/molcells.2021.0076", "PMC8490202", "34518443"]}, {"Citation": "Than TT, et al. Ankyrin repeat domain 1 is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry. Sci. Rep. 2016;6:20819. doi: 10.1038/srep20819.", "ArticleIdList": ["10.1038/srep20819", "PMC4748412", "26860204"]}, {"Citation": "Amraei R, et al. Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 2022;119:e2113874119. doi: 10.1073/pnas.2113874119.", "ArticleIdList": ["10.1073/pnas.2113874119", "PMC8833221", "35078919"]}, {"Citation": "Suprewicz \u0141, et al. Extracellular vimentin as a target against SARS-CoV-2 host cell invasion. Small. 2022;18:2105640. doi: 10.1002/smll.202105640.", "ArticleIdList": ["10.1002/smll.202105640", "PMC9252327", "34866333"]}, {"Citation": "Lee HY, et al. Inhibition of HCV replicon cell growth by 2-Arylbenzofuran derivatives isolated from Mori Cortex radicis. Planta Med. 2007;73:1481\u20131485. doi: 10.1055/s-2007-990249.", "ArticleIdList": ["10.1055/s-2007-990249", "17948170"]}, {"Citation": "Kim JW, et al. Triterpenoid saponins isolated from Platycodon grandiflorum inhibit hepatitis C virus replication. Evid. Based Complementary Altern. Med. 2013;2013:560417. doi: 10.1155/2013/560417.", "ArticleIdList": ["10.1155/2013/560417", "PMC3893781", "24489585"]}, {"Citation": "Lee J, et al. Saponin inhibits hepatitis C virus propagation by up-regulating suppressor of cytokine signaling 2. PLoS One. 2012;7:e39366. doi: 10.1371/journal.pone.0039366.", "ArticleIdList": ["10.1371/journal.pone.0039366", "PMC3379970", "22745742"]}, {"Citation": "Sayed AM, et al. Nature as a treasure trove of potential anti-SARS-CoV drug leads: A structural/mechanistic rationale. RSC Adv. 2020;10:19790\u201319802. doi: 10.1039/D0RA04199H.", "ArticleIdList": ["10.1039/D0RA04199H", "PMC9122629", "35685913"]}, {"Citation": "Gayathri B, Manjula N, Vinaykumar K, Lakshmi B, Balakrishnan A. Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNF\u03b1, IL-1\u03b2. NO and MAP kinases. Int. Immunopharmacol. 2007;7:473\u2013482. doi: 10.1016/j.intimp.2006.12.003.", "ArticleIdList": ["10.1016/j.intimp.2006.12.003", "17321470"]}, {"Citation": "Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J. Pharm. Sci. 2011;73:255.", "ArticleIdList": ["PMC3309643", "22457547"]}, {"Citation": "Beghelli D, et al. Antioxidant and ex vivo immune system regulatory properties of Boswellia serrata extracts. Oxid. Med. Cell. Longev. 2017;2017:7468064. doi: 10.1155/2017/7468064.", "ArticleIdList": ["10.1155/2017/7468064", "PMC5366763", "28386311"]}, {"Citation": "Etzel R. Special extract of Boswellia serrata (H 15) in the treatment of rheumatoid arthritis. Phytomedicine. 1996;3:91\u201394. doi: 10.1016/S0944-7113(96)80019-5.", "ArticleIdList": ["10.1016/S0944-7113(96)80019-5", "23194870"]}, {"Citation": "Gupta I, et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur. J. Med. Res. 1997;2:37\u201343.", "ArticleIdList": ["9049593"]}, {"Citation": "Gupta I, et al. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med. 2001;67:391\u2013395. doi: 10.1055/s-2001-15802.", "ArticleIdList": ["10.1055/s-2001-15802", "11488449"]}, {"Citation": "Su S, et al. Anti-inflammatory and analgesic activity of different extracts of Commiphora myrrha. J. Ethnopharmacol. 2011;134:251\u2013258. doi: 10.1016/j.jep.2010.12.003.", "ArticleIdList": ["10.1016/j.jep.2010.12.003", "21167270"]}, {"Citation": "Germano A, Occhipinti A, Barbero F, Maffei ME. A pilot study on bioactive constituents and analgesic effects of MyrLiq\u00ae, a Commiphora myrrha extract with a high furanodiene content. Biomed Res. Int. 2017;2017:3804356. doi: 10.1155/2017/3804356.", "ArticleIdList": ["10.1155/2017/3804356", "PMC5463107", "28626756"]}, {"Citation": "Mohamed AA, Ali SI, El-Baz FK, Hegazy AK, Kord MA. Chemical composition of essential oil and in vitro antioxidant and antimicrobial activities of crude extracts of Commiphora myrrha resin. Ind. Crops Prod. 2014;57:10\u201316. doi: 10.1016/j.indcrop.2014.03.017.", "ArticleIdList": ["10.1016/j.indcrop.2014.03.017"]}, {"Citation": "Ansari S, Ahmad I, Ali M, Maaz M. \u201cTiryaq Arba\u201d(a polyherbal Unani formulation) as prophylactic medicine against epidemics of acute respiratory viral infections. Middle East J. Rehabil. Health Stud. 2020;7(3):e102965. doi: 10.5812/mejrh.102965.", "ArticleIdList": ["10.5812/mejrh.102965"]}, {"Citation": "Ahmed NZ, et al. In-silico evaluation of Tiryaq-e-wabai, an Unani formulation for its potency against SARS-CoV-2 spike glycoprotein and main protease. J. Drug Deliv. Ther. 2021;11:86\u2013100. doi: 10.22270/jddt.v11i4-S.4993.", "ArticleIdList": ["10.22270/jddt.v11i4-S.4993"]}, {"Citation": "Fatima SW, Alam S, Khare SK. Molecular and structural insights of \u03b2-boswellic acid and glycyrrhizic acid as potent SARS-CoV-2 Envelope protein inhibitors. Phytomed. Plus. 2022;2:100241. doi: 10.1016/j.phyplu.2022.100241.", "ArticleIdList": ["10.1016/j.phyplu.2022.100241", "PMC8840829", "35403092"]}, {"Citation": "Roy A, Menon T. Evaluation of bioactive compounds from Boswellia serrata against SARS-CoV-2. Vegetos. 2022;35:404\u2013414. doi: 10.1007/s42535-021-00318-7.", "ArticleIdList": ["10.1007/s42535-021-00318-7", "PMC8595075", "34803247"]}, {"Citation": "Tosi B, Donini A, Romagnoli C, Bruni A. Antimicrobial activity of some commercial extracts of propolis prepared with different solvents. Phytother. Res. 1996;10:335\u2013336. doi: 10.1002/(SICI)1099-1573(199606)10:4<335::AID-PTR828>3.0.CO;2-7.", "ArticleIdList": ["10.1002/(SICI)1099-1573(199606)10:4<335::AID-PTR828>3.0.CO;2-7"]}, {"Citation": "McLennan SV, et al. The anti-inflammatory agent Propolis improves wound healing in a rodent model of experimental diabetes. Wound Repair Regen. 2008;16:706\u2013713. doi: 10.1111/j.1524-475X.2008.00421.x.", "ArticleIdList": ["10.1111/j.1524-475X.2008.00421.x", "19128266"]}, {"Citation": "Santos LM, et al. Propolis: Types, composition, biological activities, and veterinary product patent prospecting. J. Sci. Food Agric. 2020;100:1369\u20131382. doi: 10.1002/jsfa.10024.", "ArticleIdList": ["10.1002/jsfa.10024", "31487405"]}, {"Citation": "Scorza CA, et al. Propolis and coronavirus disease 2019 (COVID-19): Lessons from nature. Complement. Ther. Clin. Pract. 2020;41:101227. doi: 10.1016/j.ctcp.2020.101227.", "ArticleIdList": ["10.1016/j.ctcp.2020.101227", "PMC7415165", "32810746"]}, {"Citation": "Ali AM, Kunugi H. Propolis, bee honey, and their components protect against coronavirus disease 2019 (COVID-19): A review of in silico, in vitro, and clinical studies. Molecules. 2021;26:1232. doi: 10.3390/molecules26051232.", "ArticleIdList": ["10.3390/molecules26051232", "PMC7956496", "33669054"]}, {"Citation": "Aparecida Berretta A, Duarte Silveira MA, Condor Capcha JM, De Jong D. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease. Biomed. Pharmacother. 2020;131:110622. doi: 10.1016/j.biopha.2020.110622.", "ArticleIdList": ["10.1016/j.biopha.2020.110622", "PMC7430291", "32890967"]}, {"Citation": "Guyonnet Duperat V, et al. Characterization of the human mucin gene MUC5AC: A consensus cysteine-rich domain for 11p15 mucin genes? Biochem. J. 1995;305:211\u2013219. doi: 10.1042/bj3050211.", "ArticleIdList": ["10.1042/bj3050211", "PMC1136451", "7826332"]}, {"Citation": "Lee S, et al. SARS-CoV-2 induces expression of cytokine and MUC5AC/5B in human nasal epithelial cell through ACE 2 receptor. Biomed Res. Int. 2022;2022:2743046. doi: 10.1155/2022/2743046.", "ArticleIdList": ["10.1155/2022/2743046", "PMC9184209", "35692597"]}, {"Citation": "Morrison CB, et al. SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13. Proc. Natl. Acad. Sci. 2022;119:e2119680119. doi: 10.1073/pnas.2119680119.", "ArticleIdList": ["10.1073/pnas.2119680119", "PMC9169748", "35353667"]}, {"Citation": "Bonser LR, Zlock L, Finkbeiner W, Erle DJ. Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma. J. Clin. Investig. 2016;126:2367\u20132371. doi: 10.1172/JCI84910.", "ArticleIdList": ["10.1172/JCI84910", "PMC4887179", "27183390"]}, {"Citation": "Zhu Z, et al. Association of asthma and its genetic predisposition with the risk of severe COVID-19. J. Allergy Clin. Immunol. 2020;146:327\u2013329. doi: 10.1016/j.jaci.2020.06.001.", "ArticleIdList": ["10.1016/j.jaci.2020.06.001", "PMC7423602", "32522462"]}, {"Citation": "Foronjy RF, Dabo AJ, Cummins N, Geraghty P. Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection. BMC Immunol. 2014;15:1\u201315. doi: 10.1186/s12865-014-0041-4.", "ArticleIdList": ["10.1186/s12865-014-0041-4", "PMC4189665", "25277705"]}, {"Citation": "Quinton LJ, et al. Leukemia inhibitory factor signaling is required for lung protection during pneumonia. J Immunol. 2012;188:6300\u20136308. doi: 10.4049/jimmunol.1200256.", "ArticleIdList": ["10.4049/jimmunol.1200256", "PMC3370070", "22581855"]}, {"Citation": "Metcalfe SM. LIF and the lung\u2019s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic? Future Med. 2020;15:659\u2013662."}, {"Citation": "Giovannoni F, Li Z, Garcia CC, Quintana FJ. A potential role for AHR in SARS-CoV-2 pathology. Res. Sq. 2020;2020:2rs.3.rs-5639."}, {"Citation": "Kozaki T, et al. Mitochondrial damage elicits a TCDD-inducible poly (ADP-ribose) polymerase-mediated antiviral response. Proc. Natl. Acad. Sci. 2017;114:2681\u20132686. doi: 10.1073/pnas.1621508114.", "ArticleIdList": ["10.1073/pnas.1621508114", "PMC5347618", "28213497"]}, {"Citation": "Yamada T, et al. Constitutive aryl hydrocarbon receptor signaling constrains type I interferon\u2013mediated antiviral innate defense. Nat. Immunol. 2016;17:687\u2013694. doi: 10.1038/ni.3422.", "ArticleIdList": ["10.1038/ni.3422", "27089381"]}, {"Citation": "Zhu Y, Song D, Song Y, Wang X. Interferon gamma induces inflammatory responses through the interaction of CEACAM1 and PI3K in airway epithelial cells. J. Transl. Med. 2019;17:1\u201310. doi: 10.1186/s12967-019-1894-3.", "ArticleIdList": ["10.1186/s12967-019-1894-3", "PMC6507156", "31072323"]}, {"Citation": "Sharif-Askari NS, et al. Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection. Mol. Ther. Methods Clin. Dev. 2021;20:109\u2013121. doi: 10.1016/j.omtm.2020.11.002.", "ArticleIdList": ["10.1016/j.omtm.2020.11.002", "PMC7658590", "33200082"]}, {"Citation": "Vitenshtein A, et al. CEACAM1-mediated inhibition of virus production. Cell Rep. 2016;15:2331\u20132339. doi: 10.1016/j.celrep.2016.05.036.", "ArticleIdList": ["10.1016/j.celrep.2016.05.036", "PMC4914772", "27264178"]}, {"Citation": "Zhao B, et al. Negative regulators of inflammation response to the dynamic expression of cytokines in DF-1 and MDCK cells infected by avian influenza viruses. Inflamm. 2022;45(2):573\u2013589. doi: 10.1007/s10753-021-01568-y.", "ArticleIdList": ["10.1007/s10753-021-01568-y", "34581936"]}, {"Citation": "Rochette L, et al. GDF15: A modulator of immunity and a predictive biomarker of cardiovascular events: A strategy in COVID-19. Ann. Cardiol. Angeiol. 2023;72(1):41\u201343. doi: 10.1016/j.ancard.2022.09.001.", "ArticleIdList": ["10.1016/j.ancard.2022.09.001", "PMC9477966", "36163282"]}, {"Citation": "Babalghith AO, et al. The potential role of growth differentiation factor 15 in COVID-19: a corollary subjective effect or not? Diagnostics. 2022;12:2051. doi: 10.3390/diagnostics12092051.", "ArticleIdList": ["10.3390/diagnostics12092051", "PMC9497461", "36140453"]}, {"Citation": "Si Y, et al. Growth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma-related genes. PloS One. 2011;6:e19967. doi: 10.1371/journal.pone.0019967.", "ArticleIdList": ["10.1371/journal.pone.0019967", "PMC3100307", "21625435"]}, {"Citation": "Cheng J, et al. The regulation of ISG20 expression on SARS-CoV-2 infection in cancer patients and healthy individuals. Front. Immunol. 2022;13:958898. doi: 10.3389/fimmu.2022.958898.", "ArticleIdList": ["10.3389/fimmu.2022.958898", "PMC9513371", "36177004"]}, {"Citation": "Deymier S, Louvat C, Fiorini F, Cimarelli A. ISG20: an enigmatic antiviral RNase targeting multiple viruses. FEBS Open Bio. 2022;12:1096\u20131111. doi: 10.1002/2211-5463.13382.", "ArticleIdList": ["10.1002/2211-5463.13382", "PMC9157404", "35174977"]}, {"Citation": "Furutani Y, et al. Establishment of a rapid detection system for ISG20-dependent SARS-CoV-2 subreplicon RNA degradation induced by interferon-\u03b1. Int. J. Mol. Sci. 2021;22:11641. doi: 10.3390/ijms222111641.", "ArticleIdList": ["10.3390/ijms222111641", "PMC8583800", "34769072"]}, {"Citation": "Qu H, et al. Influenza A Virus-induced expression of ISG20 inhibits viral replication by interacting with nucleoprotein. Virus genes. 2016;52:759\u2013767. doi: 10.1007/s11262-016-1366-2.", "ArticleIdList": ["10.1007/s11262-016-1366-2", "27342813"]}, {"Citation": "Stadler D, et al. Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20. EMBO Rep. 2021;22:e49568. doi: 10.15252/embr.201949568.", "ArticleIdList": ["10.15252/embr.201949568", "PMC8183418", "33969602"]}, {"Citation": "Wickenhagen A, et al. A prenylated dsRNA sensor protects against severe COVID-19. Science. 2021;374:eabj3624. doi: 10.1126/science.abj3624.", "ArticleIdList": ["10.1126/science.abj3624", "PMC7612834", "34581622"]}, {"Citation": "Danziger O, Patel RS, DeGrace EJ, Rosen MR, Rosenberg BR. Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor. PLoS Pathog. 2022;18:e1010464. doi: 10.1371/journal.ppat.1010464.", "ArticleIdList": ["10.1371/journal.ppat.1010464", "PMC9041830", "35421191"]}, {"Citation": "Banday AR, et al. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries. Nat. Genet. 2022;54:1103\u20131116. doi: 10.1038/s41588-022-01113-z.", "ArticleIdList": ["10.1038/s41588-022-01113-z", "PMC9355882", "35835913"]}, {"Citation": "Chen J, et al. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J. Virol. 2010;84:1289\u20131301. doi: 10.1128/JVI.01281-09.", "ArticleIdList": ["10.1128/JVI.01281-09", "PMC2812346", "19906920"]}, {"Citation": "Zhang Y, et al. The diverse roles and dynamic rearrangement of vimentin during viral infection. J. Cell. Sci. 2021;134:jcs250597. doi: 10.1242/jcs.250597.", "ArticleIdList": ["10.1242/jcs.250597", "33154171"]}, {"Citation": "Yu YT-C, et al. Surface vimentin is critical for the cell entry of SARS-CoV. J. Biomed. Sci. 2016;23:1\u201310. doi: 10.1186/s12929-016-0234-7.", "ArticleIdList": ["10.1186/s12929-016-0234-7", "PMC4724099", "26801988"]}, {"Citation": "Huynh TT, et al. Amuvatinib blocks SARS-CoV-2 infection at the entry step of the viral life cycle. Microbiol. Spectr. 2023;11(3):e0510522. doi: 10.1128/spectrum.05105-22.", "ArticleIdList": ["10.1128/spectrum.05105-22", "PMC10269473", "36995225"]}, {"Citation": "Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 1938;27:493\u2013497. doi: 10.1093/oxfordjournals.aje.a118408.", "ArticleIdList": ["10.1093/oxfordjournals.aje.a118408"]}, {"Citation": "Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u20132120. doi: 10.1093/bioinformatics/btu170.", "ArticleIdList": ["10.1093/bioinformatics/btu170", "PMC4103590", "24695404"]}, {"Citation": "Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321. doi: 10.1093/bioinformatics/bts635.", "ArticleIdList": ["10.1093/bioinformatics/bts635", "PMC3530905", "23104886"]}, {"Citation": "Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 2011;12:1\u201316. doi: 10.1186/1471-2105-12-323.", "ArticleIdList": ["10.1186/1471-2105-12-323", "PMC3163565", "21816040"]}, {"Citation": "Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17:10\u201312. doi: 10.14806/ej.17.1.200.", "ArticleIdList": ["10.14806/ej.17.1.200"]}, {"Citation": "Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11:1\u20139. doi: 10.1186/gb-2010-11-3-r25.", "ArticleIdList": ["10.1186/gb-2010-11-3-r25", "PMC2864565", "20196867"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "9", "Day": "5"}, {"Year": "2023", "Month": "11", "Day": "30"}, {"Year": "2023", "Month": "12", "Day": "11", "Hour": "12", "Minute": "42"}, {"Year": "2023", "Month": "12", "Day": "7", "Hour": "0", "Minute": "42"}, {"Year": "2023", "Month": "12", "Day": "6", "Hour": "23", "Minute": "28"}, {"Year": "2023", "Month": "12", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["38057373", "PMC10700534", "10.1038/s41598-023-48854-3", "10.1038/s41598-023-48854-3"]}}], "PubmedBookArticle": []}